Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; prostate-specific antigen; neoplasm recurrence; local; prostatectomy; prognosis; ACM; all cause mortality; BCR; biochemical recurrence; CRPC; castration resistant prostate cancer; ePSADT; early PSADT; PCSM; prostate cancer specific mo
مقالات ISI مرگ و میر خاصی از سرطان پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; neoplasm metastasis; SEER Program; practice guidelines as topic; mortality; PCSM; prostate cancer specific mortality; PLNM; pelvic lymph node metastases; SEER; Surveillance, Epidemiology and End Results;
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; biopsy; diagnosis; mortality; risk; ACM; all-cause mortality; DRE; digital rectal examination; PCa; prostate cancer; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; TRUS; transrectal ultrasound;
The Effect of Radical Prostatectomy, External Beam Radiation Therapy and Active Surveillance on Life Insurance Premiums in Patients with Prostate Cancer
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; prostatectomy; radiation; watchful waiting; insurance; AS; active surveillance; EBRT; external beam radiation therapy; PCa; prostate cancer; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; RP; radical prostat
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; prostatectomy; risk; treatment outcome; ADT; androgen deprivation therapy; BCR; biochemical recurrence; BFS; biochemical recurrence-free survival; EBRT; external beam radiation therapy; EF; erectile function; HR; high risk; IIEF-5; In
Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; salvage therapy; radiotherapy; prostatectomy; prostate-specific antigen; ADT; androgen deprivation therapy; ART; adjuvant radiotherapy; bRFS; biochemical relapse-free survival; DMFS; distant metastasis-free survival; FF-SADT; freedom
SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; genomics; prognosis; neoplasm metastasis; transcriptome; BCR; biochemical recurrence; EPE; extraprostatic extension; GS; Gleason score; IHC; immunohistochemistry; KM; Kaplan-Meier; LNI; lymph node involvement; MVA; multivariable analy
The impact of PSA and digital rectal examination on the risk of prostate cancer specific mortality in men with a PSA level <2.5Â ng/ml
Keywords: مرگ و میر خاصی از سرطان پروستات; Prostate cancer; Low PSA; Digital rectal examination; Prostate cancer specific mortality; SEER program;
Causes of Death After Radical Prostatectomy at a Large Tertiary Center
Keywords: مرگ و میر خاصی از سرطان پروستات; prostate; prostatic neoplasms; prostatectomy; mortality; cause of death; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; RP; radical prostatectomy; SMR; standardized mortality ratio;
Hazard of Prostate Cancer Specific Mortality After Radical Prostatectomy
Keywords: مرگ و میر خاصی از سرطان پروستات; prostate; prostatic neoplasms; prostatectomy; mortality; proportional hazards models; GS; Gleason score; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; RP; radical prostatectomy; SEER; Surveillance, Epidemiology and End Results;
Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; watchful waiting; cardiovascular diseases; mortality; ACM; all cause mortality; AS; active surveillance; CVD; cardiovascular disease; MI; myocardial infarction; PC; prostate cancer; PCSM; prostate cancer specific mortality; PSA; prost
Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatectomy; brachytherapy; prostatic neoplasms; mortality; risk; AJCC; American Joint Committee on Cancer; AST; androgen suppression therapy; bPFS; biochemical progression-free survival; BT; brachytherapy; EBRT; external beam radiotherapy; LHRH; lutein
Hospitalization for osteoarthritis and prostate cancer specific mortality among Swedish men with prostate cancer
Keywords: مرگ و میر خاصی از سرطان پروستات; NSAIDs; Osteoarthritis; Prostate cancer specific mortality
Positive Surgical Margins at Radical Prostatectomy Predict Prostate Cancer Specific Mortality
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; survival; population groups; prostatectomy; BCR; biochemical recurrence; DSS; disease specific survival; NSM; negative surgical margin; PCa; prostate cancer; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; PS
Pretreatment Predictors of Death From Other Causes in Men With Prostate Cancer
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; mortality; therapeutics; CaPSURE; Cancer of the Prostate Strategic Urologic Research Endeavor; GU; genitourinary; I-PSS; International Prostate Symptom Score; LDH; lactate dehydrogenase; OCM; other cause mortality; PCSM; prostate canc
Evidence to Support a Continued Stage Migration and Decrease in Prostate Cancer Specific Mortality
Keywords: مرگ و میر خاصی از سرطان پروستات; prostatic neoplasms; prostate-specific antigen; prostatectomy; mass screening; treatment failure; AJCC; American Joint Committee on Cancer; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; PSA-DT; prostate specific antigen doublin